Participation in Swiss mammography screening programmes: Key role of physicians;Fidélisation aux programmes de dépistage du cancer du sein en Suisse: Rôle central du médecin

Praxis

Volumn 94, Issue 36, 2005, Pages 1381-1387

  Bulliard, J L ^a   De Landtsheer, J P ^b   Levi, F ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Fondation Depistage Cancer du Sein   (Switzerland)

Author keywords

Breast cancer; Evaluation; Mammography; Participation; Screening programmes; Switzerland

Indexed keywords

EID: 80051665916     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.94.36.1381     Document Type: Article

References (36)

1. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-54.
2. International Agency for Research on Cancer. Breast cancer screening. IARC Handbooks of Cancer Prevention, Vainio H, Bianchini F eds, Vol. 7, 2002, Lyon: IARC Press, 229 p.
3. Ministry of Health. Interim National Quality Standards: New Zealand breast cancer screening programme. 1996, Ministry of Health:Wellington, 69 p.
4. Europe Against Cancer. European guidelines for quality assurance in mammography screening. 3rd ed, Perry N, Broeders M, de Wolf C, et al. eds, 2001, Luxembourg: Office for Official Publications of the European Communities, 366 p.
5. Commonwealth Department of Human Services and Health. National program for the early detection of breast cancer: national accreditation requirements, March 1994, Canberra: Commonwealth Department of Human Services and Health.
6. Cockburn J, Schofield P, White V, et al. Predictors of returning for second round screening at a population based mammographic screening programme in Melbourne, Australia. J Epidemiol Community Health 1997;51:62-6. (Pubitemid 27095938)
7. Orton M, Fitzpatrick R, Fuller A, et al. Factors affecting women's response to an invitation to attend for a second breast cancer screening examination. Br J Gen Pract 1991;41:320-2.
8. Drossaert CH, Boer H, Seydel ER. Does mammographic screening and a negative result affect attitudes towards future breast screening? J Med Screen 2001;8:204-12. (Pubitemid 34074935)
9. O'Byrne AM, Kavanagh AM, Ugoni A, et al. Predictors of non-attendance for second round mammography in an Australian mammographic screening programme. J Med Screen 2000;7:190-4. (Pubitemid 32099056)
10. Tatla RK, Paszat LF, Bondy SJ, et al. Socioeconomic status & returning for a second screen in the Ontario breast screening program. The Breast 2003;12:237-46. (Pubitemid 36944149)
11. Bulliard J-L, De Landtsheer J-P, Levi F. Results from the Swiss mammography screening pilot programme. Eur J Cancer 2003;38:1760-8.
12. Bulliard J-L, De Landtsheer J-P, Levi F. Reattendance in the Swiss mammography screening pilot programme. J Med Screen 2004;11:59-64. (Pubitemid 38829882)
13. Bulliard J-L, De Landtsheer J-P, Levi F. Profile of women not attending in the Swiss Mammography Screening Pilot Programme. The Breast 2004;13:284-9. (Pubitemid 39172728)
14. Meystre-Agustoni G, Dubois-Arber F, De Landtsheer J-P, et al. Exploring the reasons for non-participation of women in a breast cancer screening campaign. Eur J Public Hlth 1998;8:143-5. (Pubitemid 28292501)
15. Hofvind SS-H, Wang H, Thoresen S. The Norwegian Breast Cancer Screening Program: re-attendance related to the women's experiences, intentions and previous screening result. Cancer Causes Control 2003;14:391-8. (Pubitemid 36735110)
16. Sutton S, Bickler G, Sancho-Aldridge J, et al. Prospective study of predictors of attendance for breast screening in inner London. J Epidemiol Community Health 1994;48:65-73. (Pubitemid 24083364)
17. De Landtsheer J-P, Delanoy Ortega B, Jemelin C. Dépistage du cancer du sein: analyse comparée de trois programmes suisses. Méd Hyg 2000;58:1407-10.
18. Johnson MM, Hislop TG, Kan L, et al. Compliance with the screening mammography program of British Columbia: will she return? Can J Public Health 1996;87:176-80. (Pubitemid 26265712)
19. Scaf-Klomp W, van Sonderen FL, Stewart R, et al. Compliance after 17 years of breast cancer screening. J Med Screen 1995;2:195-9.
20. Scaf-Klomp W, Sanderman R, van de Wiel HB, et al. Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community Health 1997;51:705-10. (Pubitemid 28014250)
21. Marshall G. A comparative study of re-attenders and non-re-attenders for second triennial National Breast Screening Programme appointments. J Public Health Med 1994;16:79-86. (Pubitemid 24094222)
22. Potter SJ, Mauldin PD, Hill HA. Access to and participation in breast cancer screening: a review of recent literature. Clin Perform Qual Health Care 1996;4:74-85.
23. Roter DL, Hall JA, Aoki Y. Physician gender effects in medical communication: a meta-analytic review. JAMA 2002;288:756-64. (Pubitemid 34848232)
24. Lurie N, Margolis KL, McGovern PG, et al. Why do patients of female physicians have higher rates of breast and cervical cancer screening? J Gen Intern Med 1997;12:34-43. (Pubitemid 27114064)
25. Lane DS, Messina CR. Current perspectives on physician barriers to breast cancer screening. J Am Board Fam Pract 1999;12:8-15.
26. Taplin SH, Taylor V, Montano D, et al. Specialty differences and the ordering of screening mammography by primary care physicians. J Am Board Fam Pract 1994;7:375-86.
27. Haggerty J, Tamblyn R, Abrahamowicz M, et al. Screening mammography referral rates for women ages 50 to 69 years by recently-licensed family physicians: physician and practice environment correlates. Prev Med 1999;29:391-404.
28. Osborn EH, Bird JA, McPhee SJ, et al. Cancer screening by primary care physicians. Can we explain the differences? J Fam Pract 1991;32:465-71.
29. Lurie N, Slater J, McGovern P, et al. Preventive care for women. Does the sex of the physician matter? N Engl J Med 1993;329:478-82. (Pubitemid 23222335)
30. Henderson JT, Weisman CS. Physician gender effects on preventive screening and counseling: an analysis of male and female patients' health care experiences. Med Care 2001;39:1281-92. (Pubitemid 33603672)
31. Keller B, Stutz EZ, Tibblin M, et al. Screening mammographies in Switzerland: what makes female and male physicians prescribe them? Swiss Med Wkly 2001;131:311-9. (Pubitemid 32601561)
32. Meystre-Agustoni G, Paccaud F, Jeannin A, et al. Anxiety in a cohort of Swiss women participating in a mammographic screening programme. J Med Screen 2001;8:213-9. (Pubitemid 34074936)
33. Rutter DR, Calnan M, Field S, et al. Predicting reattendance in the second round of the UK National Breast Screening Programme: a prospective 3-year longitudinal analysis. The Breast 1997;6:120-5. (Pubitemid 27254897)
34. Rutter DR. Attendance and reattendance for breast cancer screening: a prospective 3-year test of the theory of planned behaviour. Br J Health Psychol 2000;5:1-13. (Pubitemid 30088781)
35. Lagerlund M, Widmark C, Lambe M, et al. Rationales for attending or not attending mammography screening - a focus group study among women in Sweden. Eur J Cancer Prev 2001;10:429-42. (Pubitemid 33016254)
36. Aro AR, de Koning HJ, Absetz P, et al. Two distinct groups of non-attenders in an organized mammography screening program. Breast Cancer Res Treat 2001;70:145-53. (Pubitemid 33139673)